Huella digital
Colaboraciones y áreas de investigación principales de los últimos cinco años
-
Accessing the Pancreatobiliary System via Lumen-Apposing Metal Stents: A State-of-the-Art Review of Endoscopic Ultrasound-Directed Interventions
Vanella, G., Bronswijk, M., Pérez-Cuadrado-Robles, E., van Wanrooij, R. L. J., Chahal, P., Forti, E., Gallo, C., Spadaccini, M., Fugazza, A., Khashab, M., Sethi, A., Tyberg, A., Perez-Miranda, M., Mutignani, M., Kunda, R., Kahaleh, M., Van der Merwe, S. & Arcidiacono, P. G., feb 2026, En: Digestive Endoscopy. 38, 2, e70098.Producción científica: Review article › revisión exhaustiva
Acceso abierto -
Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction–Associated Steatohepatitis
Frias, J., Schmouder, R., Lawitz, E., Zhang, Y., Zhou, H., Badman, M. K., Ukomadu, C., Weiss, H. M., Zack, J., Yadav, B., Martic, M., Drakeford, C., Koo, P., Naoumov, N. V. & Greenbaum, L. E., mar 2026, En: Alimentary Pharmacology and Therapeutics. 63, 5, p. 637-647 11 p.Producción científica: Article › revisión exhaustiva
Acceso abierto3 !!Link opens in a new tab Citas (Scopus) -
Editorial: Combination Therapies for MASH: A Step Forward or More Complexity? Authors' Reply
Lawitz, E. & Greenbaum, L., mar 2026, En: Alimentary Pharmacology and Therapeutics. 63, 6, p. 905-906 2 p.Producción científica: Editorial › revisión exhaustiva
Conjuntos de datos
-
A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection
Zoulim, F. (Creator), Moreno, C. (Creator), Lee, S. S. (Creator), Buggisch, P. (Creator), Horban, A. (Creator), Lawitz, E. (Creator), Corbett, C. (Creator), Lenz, O. (Creator), Fevery, B. (Creator), Verbinnen, T. (Creator), Shukla, U. (Creator) & Jessner, W. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.3990051, https://figshare.com/collections/A_3-year_follow-up_study_after_treatment_with_simeprevir_in_combination_with_pegylated_interferon-_and_ribavirin_for_chronic_hepatitis_C_virus_infection/3990051
Dataset
-
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B
Feld, J. J. (Creator), Lawitz, E. (Creator), Nguyen, T. (Creator), Lalezari, J. (Creator), Hassanein, T. (Creator), Martin, P. (Creator), Han, S.-H. (Creator), Dieterich, D. (Creator), Giard, J.-M. (Creator), De La Rosa, G. (Creator), Ahmad, A. (Creator), Luo, E. (Creator), Conery, A. L. (Creator) & Adda, N. (Creator), SAGE Journals, 2022
DOI: 10.25384/sage.c.6301764, https://sage.figshare.com/collections/EDP-514_in_healthy_subjects_and_nucleos_t_ide_reverse_transcriptase_inhibitor-suppressed_patients_with_chronic_hepatitis_B/6301764
Dataset
-
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B
Feld, J. J. (Creator), Lawitz, E. (Creator), Nguyen, T. (Creator), Lalezari, J. (Creator), Hassanein, T. (Creator), Martin, P. (Creator), Han, S.-H. (Creator), Dieterich, D. (Creator), Giard, J.-M. (Creator), De La Rosa, G. (Creator), Ahmad, A. (Creator), Luo, E. (Creator), Conery, A. L. (Creator) & Adda, N. (Creator), SAGE Journals, 2022
DOI: 10.25384/sage.c.6301764.v1, https://sage.figshare.com/collections/EDP-514_in_healthy_subjects_and_nucleos_t_ide_reverse_transcriptase_inhibitor-suppressed_patients_with_chronic_hepatitis_B/6301764/1
Dataset